Allergan Textured Breast Implant Injury Lawyers

Filing Claims Against Allergan for Causing Lymphoma

In July of 2019, the Food and Drug Administration issued a notice requesting that pharmaceutical company Allergan recall its textured breast implants. The administration found that Allergan’s textured breast implants placed those who received them at a significantly higher risk of cancer known as breast implant-associated anaplastic large cell lymphoma or BIA-ALCL.

If you’ve suffered from BIA-ALCL and are the recipient of Allergan textured breast implants, contact Arnold & Itkin today. Our Allergan breast implant injury attorneys are ready to provide a free consultation: (888) 493-1629.

Details About the Allergan Textured Breast Implant Recall

Women choose textured breast implants because their rough surfaces interact with body tissue and help them stay in place. The FDA’s recall of Allergan’s breast implants comes after 38 countries already recalled the company’s products. Initial worries over the safety of Allergan textured breast implants began in March of 2017. The FDA resisted an initial recall because the administration stated that it needed to further study the issue. By the time of its July 2019 recall, the FDA confirmed that the textured implants had a significant correlation with BIA-ALCL.

The administration found that, out of 573 cases of BIA-ALCL in the world, 481 of them were linked to Allergan textured breast implants. This is nearly 84 percent of all global cases of BIA-ALCL, and the FDA found that those with Allergan implants are six times more likely to develop cancer.

What Is BIA-ALCL?

As a rare cancer, the correlation between BIA-ALCL and recipients of Allergan implants is concerning. The cancer is found in the scar tissue and fluids near a breast implant. In some cases, cancer can spread to other parts of the body. Notably, it can take up to 10 years for symptoms to appear.

Swelling near breast implants
Pain near breast implants
Skin irritation

If a person is diagnosed with BIA-ALCL, the FDA suggests that they remove the implant, including the scar capsule near the implants. This is an extensive operation but is necessary to remove the tissues associated with BIA-ALCL. This rare form of cancer has claimed the lives of 33 women. Of the 13 deaths in which an implant manufacturer has been identified, investigators confirmed that 12 of them had Allergan implants.

What Does The FDA Suggest to Those with Textured Implants?

Currently, the FDA does not recommend that those free of BIA-ALCL symptom have their implants removed. Instead, the administration has urged those with textured implants to monitor and report any changes to their healthcare provider. Cancer from textured implants can take years to develop, so the FDA suggests close and regular monitoring for symptoms.

What Can Those Who Are Suffering from BIA-ALCL Do?

If you’re suffering from BIA-ALCL because of Allergan implants, help is available. Arnold & Itkin fights for the compensation that clients need after suffering from the irresponsible behavior of pharmaceutical companies. We’ve taken on some of the largest pharmaceutical companies in the world, including Johnson & Johnson, and we have won billions in record-setting victories so clients could get their lives back on track.

Notably, Allergan did not voluntarily recall its textured breast implants in the U.S., even when 38 countries had already ordered their product to stop being used. It only did so after an FDA request. While nothing will change what happened to you because of this product, you can hold this company accountable by calling us. We have answers for what happened, and we can help you get the financial relief you need to move forward.

Call us today to find out what to do next at (888) 493-1629. A member of our team is available to hear your story.